530057 Stock Overview
Engages in the research and development, manufacturing, and the distribution of pharmaceutical products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Vivanza Biosciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4.03 |
| 52 Week High | ₹11.72 |
| 52 Week Low | ₹3.36 |
| Beta | 0.78 |
| 11 Month Change | 14.49% |
| 3 Month Change | -14.26% |
| 1 Year Change | -46.41% |
| 33 Year Change | -78.74% |
| 5 Year Change | 170.47% |
| Change since IPO | -15.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530057 | IN Medical Equipment | IN Market | |
|---|---|---|---|
| 7D | -3.4% | -1.7% | 0.3% |
| 1Y | -46.4% | 66.2% | 27.3% |
Return vs Industry: 530057 underperformed the Indian Medical Equipment industry which returned 66.2% over the past year.
Return vs Market: 530057 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 530057 volatility | |
|---|---|
| 530057 Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 530057 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 530057's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 5 | Jayendra Mehta | www.vivanzabiosciences.com |
Vivanza Biosciences Limited engages in the research and development, manufacturing, and the distribution of pharmaceutical products in India. It offers latex surgical and examination, and latex free gloves, as well as other surgical products. The company was incorporated in 1982 and is based in Ahmedabad, India.
Vivanza Biosciences Limited Fundamentals Summary
| 530057 fundamental statistics | |
|---|---|
| Market cap | ₹156.00m |
| Earnings (TTM) | ₹733.00k |
| Revenue (TTM) | ₹164.18m |
219.9x
P/E Ratio1.0x
P/S RatioIs 530057 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530057 income statement (TTM) | |
|---|---|
| Revenue | ₹164.18m |
| Cost of Revenue | ₹149.28m |
| Gross Profit | ₹14.90m |
| Other Expenses | ₹14.16m |
| Earnings | ₹733.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.018 |
| Gross Margin | 9.07% |
| Net Profit Margin | 0.45% |
| Debt/Equity Ratio | 126.8% |
How did 530057 perform over the long term?
See historical performance and comparison